Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-Related Macular Disease: One-Year Results of the Randomized Canadian Treat-and-Extend Analysis Trial with Ranibizumab Study |
| |
| Affiliation: | 1. The John and Liz Tory Eye Centre, Sunnybrook Health Sciences Center, and University of Toronto, Toronto, Canada;2. Montreal Retina Institute, and McGill University, Montreal, Canada;3. Alberta Retina Consultants, and University of Alberta, Edmonton, Canada;4. Calgary Retina Consultants, and University of Calgary, Calgary, Canada;5. JSS Medical Research, Saint-Laurent, Canada;6. Novartis Pharmaceuticals Canada, Dorval, Canada;7. Ivey Eye Institute, and Western University, London, Canada |
| |
| Abstract: | ![]()
|
| |
| Keywords: | BCVA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0015" }," $$" :[{" #name" :" text" ," _" :" best-corrected visual acuity CATT" },{" #name" :" keyword" ," $" :{" id" :" kwrd0025" }," $$" :[{" #name" :" text" ," _" :" Comparison of Age-Related Macular Degeneration Treatments Trials ETDRS" },{" #name" :" keyword" ," $" :{" id" :" kwrd0035" }," $$" :[{" #name" :" text" ," _" :" Early Treatment Diabetic Retinopathy Study FA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0045" }," $$" :[{" #name" :" text" ," _" :" fluorescein angiography nAMD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0055" }," $$" :[{" #name" :" text" ," _" :" neovascular age-related macular degeneration PRN" },{" #name" :" keyword" ," $" :{" id" :" kwrd0065" }," $$" :[{" #name" :" text" ," _" :" pro re nata SD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0075" }," $$" :[{" #name" :" text" ," _" :" standard deviation T&E" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" treat and extend VA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0095" }," $$" :[{" #name" :" text" ," _" :" visual acuity |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
